enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asthma - drugs for obstructive airway diseases, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
caramlo hct apontis 16 mg/10 mg/12,5 mg hartkapseln
caramlo hct apontis 16 mg/5 mg/12,5 mg hartkapseln
apontis topical external sprays without gas
shebac pharma; norvik enterprises limited - topical external sprays without gas
tonotec lipid 10 mg/10 mg/40 mg tabletten
tonotec lipid 5 mg/5 mg/20 mg tabletten
tonotec lipid 10 mg/5 mg/20 mg tabletten
tonotec lipid 5 mg/5 mg/10 mg tabletten
tonotec lipid 10 mg/10 mg/20 mg tabletten
rosuvalsa apontis 20 mg/160 mg filmtabletten